Huntington's disease protein has broader effects on brain, study shows

Apr 05, 2011

In Huntington's disease, the mutant protein known as huntingtin leads to the degeneration of a part of the brain known as the basal ganglia, causing the motor disturbances that represent one of the most defining features of the fatal disease. But a new study reported in the April issue of Cell Metabolism, a Cell Press publication, shows that the mutant protein also is responsible for metabolic imbalances in the hypothalamus, a brain region that plays an important role in appetite control.

"This helps to explain and increases in appetite that have been observed in people at the early stages of disease," even before any motor symptoms appear, said Åsa Petersén of Lund University in Sweden. "It should encourage us to do more clinical studies. If we really understand the pathways that are affected, it may lead to new targets for intervention."

The clinical diagnosis of Huntington's disease is based entirely on the presence of overt motor dysfunction. But, in fact, Petersén said, the original publication that defined the disease back in 1872 described a wide spectrum of problems: motor abnormalities, depression, cognitive decline and changes in body weight among them. Subsequent studies of the Huntington's brain traced the motor disturbances to massive losses of the . "Those findings overshadowed other changes," Petersén said.

But Petersén spends half of her time working as a clinician. She sees people with a diagnosis of Huntington's disease and carriers of the disease – people who know they carry the mutant gene and are therefore guaranteed to get the disease but who don't yet have any motor symptoms at all. "They complain about other symptoms," she said, including depression, anxiety, sleep disturbances and increases in appetite and weight.

Those anecdotes led her to suspect that the , which is ubiquitously expressed, might have effects on other parts of the brain, and the hypothalamus in particular. In an earlier study, she examined the brains of Huntington's carriers to find structural changes in the hypothalamus that could be observed 10 years before motor symptoms set in, along with shifts in brain chemistry.

In the new study, Petersén and her colleagues set out to confirm that those metabolic abnormalities are due to the effects of mutant huntingtin. First they showed that mice with develop impaired glucose metabolism along with pronounced resistance to insulin and the fat hormone leptin. Those metabolic symptoms could be reproduced in mice that only expressed the mutant huntingtin in the hypothalamus. When the researchers disabled the mutant huntingtin protein only in the hypothalamus, those metabolic disturbances disappeared.

"Our findings establish a causal link between mutant huntingtin expression in the and metabolic dysfunction," the researchers wrote. They also suggest that metabolic parameters could serve as powerful readouts for assessing therapies aimed at treating the disease by targeting the mutant protein in the brain.

Petersén says she suspects the mutant huntingtin will ultimately be found to influence other processes, both in the brain and in other tissues. She has plans to further explore the connection between the mutant protein and the depression, anxiety and other symptoms that also may be early signs of the disease.

In the broader scheme of things, she says the new findings highlight the important links between the study of metabolism and neuroscience. "There's a lot to be gained through cross-fertilization between the two fields," she said.

Explore further: Education, breastfeeding and gender affect the microbes on our bodies

add to favorites email to friend print save as pdf

Related Stories

Metabolic disorder underlies Huntington's disease

Oct 19, 2006

A metabolic disorder underlies the brain effects found in those with Huntington's disease, researchers report in an advance article publishing online October 19, 2006. The article will appear in the November 2006 issue of ...

Researchers discover zip codes for protein

Jan 29, 2007

McMaster scientists are very close to defining small molecule drugs that should be able to redirect the huntingtin protein from accumulating in the wrong place within brain cells, which could potentially translate to a therapy ...

Recommended for you

Leeches help save woman's ear after pit bull mauling

6 hours ago

(HealthDay)—A pit bull attack in July 2013 left a 19-year-old woman with her left ear ripped from her head, leaving an open wound. After preserving the ear, the surgical team started with a reconnection ...

New pain relief targets discovered

18 hours ago

Scientists have identified new pain relief targets that could be used to provide relief from chemotherapy-induced pain. BBSRC-funded researchers at King's College London made the discovery when researching ...

Building 'smart' cell-based therapies

18 hours ago

A Northwestern University synthetic biology team has created a new technology for modifying human cells to create programmable therapeutics that could travel the body and selectively target cancer and other ...

User comments : 0

More news stories

Vietnam battles fatal measles outbreak

Vietnam is scrambling to contain a deadly outbreak of measles that has killed more than 100 people, mostly young children, and infected thousands more this year, the government said Friday.

Under some LED bulbs whites aren't 'whiter than white'

For years, companies have been adding whiteners to laundry detergent, paints, plastics, paper and fabrics to make whites look "whiter than white," but now, with a switch away from incandescent and fluorescent lighting, different ...